Q3 2026

Filed Apr 16, 2026 · 10-Q · 47 days after period end · 0001683168-26-003012

Q3 2026 · 10-Q

Revenue

$11.21K

−25.0% vs Q3 2025

Net Income

-$103.93K

N/M vs Q3 2025

EPS Diluted

-$0.00

N/M vs Q3 2025

Gross Profit$8,160N/M

Operating Income

Same quarter

Metric	Q3 2026	Q3 2025	Q3 2024	Q3 2023
Revenue	$11.21K	$14.93K	$36.41K	$51.25K
Net Income	-$103.93K	-$181.24K	-$209.19K	-$324.66K
EPS Diluted	-$0.00	-$0.00	-$0.00	-$0.00

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Cannabis Bioscience International Holdings, Inc. · CIK 1411057 · Engraved from SEC EDGAR